Expression of CDC25 phosphatases in human gastric cancer

Digestive Diseases and Sciences

Volumn 53, Issue 4, 2008, Pages 949-953

  Xing, Xiangbin ^a   Chen, Jie ^a   Chen, Minhu ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

c myc; CDC25A; CDC25B; Cell cycle; Gastric cancer

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE A; PROTEIN TYROSINE PHOSPHATASE B; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CDC25 PHOSPHATASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-MYC; STOMACH NEOPLASMS;

EID: 40749160519     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9964-4     Document Type: Article

References (34)

1. Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18-29
2. Correa P, Shiao YH (1994) Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 54(7 Suppl):1941s-1943s
3. Farber E (1988) Cancer development and its natural history. A cancer prevention perspective. Cancer 62(8 Suppl):1676-1679
4. Farber E (1980) Reversible and irreversible lesions in processes of cancer development. IARC Sci Publ (27):143-151
5. Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Path Microbiol Scand 64:31-49
6. Moss SF (1998) Cellular markers in the gastric precancerous process. Aliment Pharmacol Ther 12(Suppl 1):91-109
7. Nurse P (1994) Ordering S phase and M phase in the cell cycle. Cell 79:547-550
8. Ebert MP, Yu J, Sung JJ, Malfertheiner P (2000) Molecular alterations in gastric cancer: the role of Helicobacter pylori. Eur J Gastroenterol Hepatol 12:795-798
9. Nigg EA (1995) Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17:471-480
10. Morgan D (1995) Principles of cdk regulation. Nature 374:131-134
11. Pines J (1993) Cyclins and cyclin-dependent kinases: take your partners. Trends Biochem Sci 18:195-197
12. Galaktionov K, Beach D (1991) Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell 67:1181-1194
13. Nagata A, Igarashi M, Jinno S, Suto K, Okayama H (1991) An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells. New Biol 3:959-968
14. Galaktionov K, Jessus C, Beach D (1995) Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Dev 9:1046-1058
15. Hernandez S, Hernandez L, Bea S, Pinyol M, Nayach I, Bellosillo B et al (2000) Cdc25a and the splicing variant cdc25b2, but not cdc25b1, -b3 or -c are over-expressed in aggressive human non-Hodgkin's lymphomas. Int J Cancer 89:148-152
16. Wu W, Fan YH, Kemp BL, Walsh G, Mao L (1998) Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc. Cancer Res 58:4082-4085
17. Hernandez S, Hernandez L, Bea S, Cazorla M, Fernandez PL, Nadal A et al (1998) Cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas. Cancer Res 58:1762-1767
18. Gasparotto D, Maestro R, Piccinin S, Vukosavljevic T, Barzan L, Sulfaro S et al (1997) Overexpression of CDC25A and CDC25B in head and neck cancers. Cancer Res 57:2366-2368
19. Yao Y, Slosberg ED, Wang L, Hibshoosh H, Zhang YJ, Xing WQ et al (1999) Increased susceptibility to carcinogen-induced mammary tumors in MMTV-Cdc25B transgenic mice. Oncogene 18:5159-5166
20. Broggini M, Buraggi G, Brenna A, Riva L, Codegoni AM, Torri V et al (2000) Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients. Anticancer Res 20:4835-4840
21. Askew DS, Ashmun RA, Simmons BC, Cleveland JL (1991) Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915-1922
22. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR (1992) Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212-214
23. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M et al (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128
24. Yokota J, Tsunetsugu-Yokota Y, Battifora H, Le Fevre C, Cline MJ (1986) Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. Science 231:261-265
25. Korc M, Meltzer P, Trent J (1986) Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer. Proc Natl Acad Sci USA 83:5141-5144
26. Kozbor D, Croce CM (1984) Amplification of the c-myc oncogene in one of five human breast carcinoma cell lines. Cancer Res 44:438-441
27. Alitalo K, Schwab M, Lin CC, Varmus HE, Bishop JM (1983) Homogeneously staining chromosomal regions contain amplified copies of an abundantly expressed cellular oncogene (c-myc) in malignant neuroendocrine cells from a human colon carcinoma. Proc Natl Acad Sci USA 80:1707-1711
28. Collins S, Groudine M (1982) Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature 298:679-681
29. Kim YJ, Ghu HD, Kim DY, Kim HJ, Kim SK, Park CS (1993) Expression of cellular oncogenes in human gastric carcinoma: c-myc, c-erb B2, and c-Ha-ras. J Surg Oncol 54:167-170
30. Ninomiya I, Yonemura Y, Matsumoto H, Sugiyama K, Kamata T, Miwa K et al (1991) Expression of c-myc gene product in gastric carcinoma. Oncology 48:149-153
31. Han S, Kim HY, Park K, Cho HJ, Lee MS, Kim HJ et al (1999) C-myc expression is related with cell proliferation and associated with poor clinical outcome in human gastric cancer. J Korean Med Sci 14:526-530
32. Sanz-Ortega J, Steinberg SM, Moro E, Saez M, Lopez JA, Sierra E et al (2000) Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer. Histol Histopathol 15:455-462
33. Galaktionov K, Chen X, Beach D (1996) Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517
34. Anti M, Armuzzi A, Gasbarrini G (1998) Epithelial cell turnover and apoptosis. Ital J Gastroenterol Hepatol 30(Suppl 3):S276-S278